Skip to content

We are supported by referral fees from the advertisers presented on this site. We do not present information about every advertiser or offer available.

Semaglutide.now
Semaglutide

Found vs Maximus: Biology-first care vs direct-pay semaglutide plans

Found vs Maximus: quick verdict

Found vs Maximus compares a biology-first, insurance-friendly program from Found with a straightforward, low flat rate compounded semaglutide program from Maximus. Early verdict: Found focuses on personalized, medically supervised weight loss with insurance options and plans starting as low as $39, while Maximus is a direct-pay telemedicine option priced at $132.99/month for compounded semaglutide.

Explore Found plans starting as low as $39

Key differences to know

When comparing Found vs Maximus, three to five distinctive differences stand out and drive choice: pricing and insurance handling, care model and personalization, medication sourcing and types, program transparency and availability, and membership or refund details. Below we compare these elements directly using only supplied facts.

1. Pricing and insurance handling

Found: Advertises getting started for as low as $39 and highlights “Affordable monthly plans” and that “Most insurance now accepted.” Found also states advertised pricing for brand-name GLP-1s via insurance with 12 month commitment and that medication coverage and copays vary based on eligibility and insurance approval.

Maximus: Uses a direct-pay model with a low flat rate at $132.99/month. Maximus does not bill insurance according to the supplied facts, so the monthly cost is what you pay.

2. Care model and personalization

Found: Emphasizes a “biology-first” approach and “personalized medically supervised program” that targets hormones, metabolism, sleep, and behavior. Found conducts a medical evaluation and builds individualized programs.

Maximus: Positions itself as convenient telemedicine access with prescriptions approved by licensed doctors, no in-person visits, and a simple direct-pay model focused on delivering compounded semaglutide. Maximus highlights convenient telemedicine access but does not advertise the same level of personalized biology-first programming.

3. Medication types and pharmacy sourcing

Found: Mentions tirzepatide and semaglutide, including compounded options, and notes that “Compounded GLP-1s are not FDA-approved or evaluated for safety or efficacy, and not available in all states.” Found also references availability of brand-name GLP-1s like Wegovy and Zepbound through insurance in some cases and includes regulatory qualifiers.

Maximus: Offers compounded semaglutide filled through trusted U.S. pharmacies. Maximus notes the medication is compounded and that prescriptions are approved by licensed doctors. Maximus does not list branded Ozempic or Wegovy availability in the supplied facts and operates as a compounded-only provider in the captured information.

4. Availability, shipping, and refunds

Found: States “Get started for as low as $39” and that it handles insurance paperwork for eligible members. Found advertises offers and membership pricing with various qualifiers and notes medications and coverage vary by insurance and eligibility.

Maximus: States free priority or expedited shipping in the landing evidence and that if you are not approved for treatment, your medication costs will be fully refunded. Maximus is available in all 50 states except Mississippi according to the captured facts.

5. Scale, track record, and program features

Found: Markets a holistic whole-body approach and personalized plans. The captured evidence emphasizes insurance acceptance for many users and multiple pricing structures including membership tiers and advertised discounts with qualifiers.

Maximus: Describes itself as a smaller, newer platform with a thinner public track record in the supplied facts, but highlights licensed doctors, domestic pharmacies, transparent direct-pay pricing, and eligibility for custom titration unless on a 90 day starter pack.

Criteria Found Maximus
Starting price Get started for as low as $39 $132.99/month direct-pay
Insurance Most insurance now accepted; Found handles paperwork No insurance billing; direct-pay only
Care model Personalized medically supervised, biology-first programs Telemedicine with prescriptions approved by licensed doctors
Medication sourcing Compounded options plus brand-name GLP-1s via insurance in some cases Compounded semaglutide from U.S. pharmacies
Availability & shipping Varies by eligibility and state; insurance-dependent pricing Free priority shipping; available in 49 states per captured facts
Regulatory note Compounded GLP-1s are not FDA-approved or evaluated for safety or efficacy Compounded medications are not FDA-approved and not reviewed by FDA

See Maximus $132.99/month semaglutide plan

How they compare on claims and guarantees

Found includes specific offer details and promotional qualifiers for discounts and Medicare bridge programs with exact language about availability and limits. Found also states that certain medications are FDA-approved for conditions other than weight and that compounded GLP-1s are not FDA-approved.

Maximus states that prescriptions are approved by licensed doctors, its medication is compounded in U.S. pharmacies, and if a patient is not approved for treatment their medication costs will be fully refunded. Maximus does not bill insurance according to supplied facts.

Review Found membership and benefits

Final thoughts on Found vs Maximus

Found vs Maximus is a choice between a personalized, biology-first program that integrates insurance options and multiple medication pathways, and a direct-pay telemedicine provider offering compounded semaglutide at a predictable flat monthly price of $132.99. Found emphasizes individualized medical evaluation and broader program features. Maximus emphasizes a simple telemedicine path to compounded semaglutide with licensed doctors and domestic pharmacy fulfillment.

Check Maximus availability and policies

Choose Provider guidance

Choose Found if you want a personalized, medically supervised program that targets biology, metabolism, hormones, and lifestyle and if you want a provider that handles insurance paperwork and advertises plans starting as low as $39.

Choose Maximus if you prefer a straightforward direct-pay telemedicine option focused on compounded semaglutide at a low flat rate of $132.99/month, with prescriptions approved by licensed doctors and fulfillment through U.S. pharmacies.

Ready to Compare GLP-1 Providers?

Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.

Compare All Providers →

Leave a comment

Medical disclaimer: This page is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any treatment.